Author:
Río Ramírez M.T.,Abad Santamaría N.,Izquierdo Patrón M.,Jareño Esteban J.J.,Steen B.,Pun Tam Y.W.,Melchor Íñiguez R.,Jara Chinarro B.,Villena Garrido V.,de Miguel Díez J.,Abad Fernández A.
Subject
Pulmonary and Respiratory Medicine
Reference75 articles.
1. Tumor markers in undiagnosed pleural effusions;Light;Chest,2004
2. Management of malignant pleural effusions;Antony;Eur Respir J,2001
3. Diagnostic value of Cyfra 21.1, CEA, CA 19.9, CA 15.3 and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature;Shitrit;Oncologist,2005
4. Diagnostic utility of Cyfra 21.1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions;Ferrer;Cancer,1999
5. Clinical utility of a combination of tumor markers in the diagnosis of malignant pleural effusions;Gaspar;Anticancer Res,2008